OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
21
Results
Show all
Save search
Copy query
Show results for
Unknown
(21)
Publication Date
Release Date
2022
(4)
2016
(3)
2014
(3)
2015
(2)
2013
(2)
2010
(2)
2025
(1)
2023
(1)
2021
(1)
2012
(1)
2011
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Probiotics and the intestinal tight junction barrier function.
Not available
S-EPMC12702976
|
biostudies-literature
Cite
A Combination of Amino Acid Mutations Leads to Resistance to Multiple Nucleoside Analogs in Reverse Transcriptases from HIV-1 Subtypes B and C.
Not available
S-EPMC8765311
|
biostudies-literature
Cite
HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells.
Not available
S-EPMC4262401
|
biostudies-literature
Cite
Ablation of cDC2 development by triple mutations within the Zeb2 enhancer.
Not available
S-EPMC10358283
|
biostudies-literature
Cite
Inhibition of histone acetyltransferase function radiosensitizes CREBBP/EP300 mutants via repression of homologous recombination, potentially targeting a gain of function.
Not available
S-EPMC8566594
|
biostudies-literature
Cite
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.
Not available
S-EPMC8693692
|
biostudies-literature
Cite
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts : National Harbor, MD, USA. 9-13 November 2016
Not available
S-EPMC5260784
|
biostudies-literature
Cite
Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration.
Not available
S-EPMC2867722
|
biostudies-literature
Cite
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results.
Not available
S-EPMC3389193
|
biostudies-literature
Cite
Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT).
Not available
S-EPMC4306628
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets